Billion dollar lawsuit against Bayer: US jury sentences the company to pay maximum damages

Billion dollar lawsuit against Bayer: US jury sentences the company to pay maximum damages

According to a report by www.finanzen.net The agricultural chemical and pharmaceutical company Bayer has been awarded $2.2 billion in damages by a US jury. The judgment concerns lawsuits involving weed killers containing glyphosate and is the highest compensation payment to date in this context. Bayer shares then came under significant pressure. The group plans to appeal and criticizes the verdict as contradicting scientific findings and assessments by the authorities.

The impact of this decision can be significant. The company's shares fell by almost 5 percent and are now just above the December low of 30.22 euros. If this value falls below, the level could be at its lowest level since 2005. Analysts estimate that higher provisions could be necessary. Bayer currently has $6.1 billion on hand for glyphosate payments and a limited amount for lawsuits related to other chemicals. There are also around 52,000 glyphosate lawsuits pending for which there has not yet been a verdict. This could lead to further financial burdens for the company.

The decision and the upcoming appeal could also affect investor confidence in Bayer and have an impact on the entire market and financial industry. It is important to closely monitor developments in this case as they could have far-reaching consequences.